Investor Overview

<< Back

News Release

Grace Enters Agreement with Valliscor to Provide Fluorinated Intermediates for the Pharmaceutical Industry

COLUMBIA,  MD., June 26, 2017 – W. R. Grace & Co. announces a Master Services  Agreement with Valliscor, an Oregon-based manufacturer of fluorinated building  blocks, to provide fluorinated intermediates that are used in a variety of  industries, including pharmaceuticals, electronics, and specialty chemicals.

The partnership brings together Valliscor’s proprietary fluoroalkylation technology with Grace’s cGMP manufacturing capability. The Albany site has more than 30 years of custom manufacturing  experience in multi-step organic, organometallic, and chiral chemistry, and integrated grams-to-kilos-to-tons production. The partnership with Valliscor brings the industry a strong U.S.-based source for the manufacture of fluorinated intermediates.

“This agreement will allow Grace to  expand our advanced intermediates business for active pharmaceutical ingredient  (API) manufacturers and enable Valliscor to broaden its market for fluoroalkylation  technology,” said Brett Reynolds, Grace’s Global Business Director, Fine Chemicals.

Recently, Grace opened a cGMP-compliant  Kilo Suite at its Albany, OR facility to produce advanced intermediates of high  quality, consistency, and control. Last year, Grace opened a cGMP release Quality Control lab in Albany, to validate analytical methods and perform GMP  release of starting materials and advanced intermediates.

“Our partnership with Valliscor and the additional capability it provides to our emerging and large pharma customer base reflects Grace’s growing commitment to this segment,” said  Sandra Wisniewski, President, Grace Materials Technologies.

About Valliscor

Founded in 2012, Valliscor is a privately held, smart  chemical manufacturer of fluorinated building blocks based in Corvallis, OR. Valliscor has developed best-in-class, proprietary technology for the  manufacture of high-purity, fluorinated building blocks. These innovations have  enabled Valliscor to become one of the biggest global producers of bromofluoromethane (BFM), which is used in the manufacture of fluticasone (the active ingredient in Flonase®, Advair® and Breo®). More information about Valliscor is available at

About Grace

Built on talent, technology, and trust, Grace is a leading global supplier of catalysts and  engineered materials. The company’s two industry-leading business  segments—Catalysts Technologies and Materials Technologies—provide innovative  products, technologies, and services that enhance the products and processes of  our customer partners around the world. With approximately 3,700 employees, Grace  operates and/or sells to customers in over 60 countries. More information about Grace is available at

Media Relations
Rich Badmington
T +1 410.531.4370

Investor Relations
Tania Almond
T +1 410.531.4590